Filing Details

Accession Number:
0001104659-24-125969
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-05 18:14:34
Reporting Period:
2024-12-03
Accepted Time:
2024-12-05 18:14:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1773427 Springworks Therapeutics Inc. SWTX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786966 Badreddin Edris C/O Springworks Therapeutics, Inc.
100 Washington Blvd.
Stamford CT 06902
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-12-03 11,966 $41.78 217,634 No 4 S Direct
Common Stock Disposition 2024-12-03 8,034 $42.24 209,600 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.09 to $42.085. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.09 to $42.555. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.